(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.28%) $11.01
(0.55%) $0.808
(-0.96%) $93.00
Live Chart Being Loaded With Signals
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs...
Stats | |
---|---|
Today's Volume | 1 786.00 |
Average Volume | 4 092.00 |
Market Cap | 111.50M |
EPS | €0 ( 2024-04-09 ) |
Next earnings date | ( €0 ) 2024-05-28 |
Last Dividend | €1.200 ( 2023-07-19 ) |
Next Dividend | €0 ( N/A ) |
P/E | 11.57 |
ATR14 | €0.513 (2.42%) |
Volume Correlation
HAEMATO AG Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
HAEMATO AG Correlation - Currency/Commodity
HAEMATO AG Financials
Annual | 2022 |
Revenue: | €248.14M |
Gross Profit: | €15.30M (6.17 %) |
EPS: | €1.570 |
Q2 | 2023 |
Revenue: | €133.64M |
Gross Profit: | €7.74M (5.79 %) |
EPS: | €0.440 |
Q4 | 2022 |
Revenue: | €127.17M |
Gross Profit: | €6.66M (5.24 %) |
EPS: | €1.410 |
Q3 | 2022 |
Revenue: | €63.58M |
Gross Profit: | €4.74M (7.46 %) |
EPS: | €0.700 |
Financial Reports:
No articles found.
HAEMATO AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€1.100 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€1.200 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €2.50 | 2011-08-26 |
Last Dividend | €1.200 | 2023-07-19 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 11 | -- |
Total Paid Out | €26.30 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.59 | -- |
Div. Sustainability Score | 9.35 | |
Div.Growth Potential Score | 3.85 | |
Div. Directional Score | 6.60 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
DCO.DE | Ex Dividend Knight | 2023-09-28 | Quarterly | 0 | 0.00% | |
LLD.DE | Ex Dividend Junior | 2023-08-03 | Annually | 0 | 0.00% | |
7BP.F | Ex Dividend Knight | 2023-09-06 | Annually | 0 | 0.00% | |
UNH.DE | Ex Dividend Knight | 2023-09-08 | Quarterly | 0 | 0.00% | |
ETG.DE | Ex Dividend Knight | 2023-07-04 | Annually | 0 | 0.00% | |
NOA3.DE | Ex Dividend Knight | 2023-10-23 | Semi-Annually | 0 | 0.00% | |
AP2.DE | Ex Dividend Knight | 2023-11-22 | Quarterly | 0 | 0.00% | |
XY6.DE | Ex Dividend Knight | 2023-08-30 | Quarterly | 0 | 0.00% | |
GZF.DE | Ex Dividend Junior | 2023-04-28 | Annually | 0 | 0.00% | |
PRU.DE | Ex Dividend Knight | 2023-09-07 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0368 | 1.500 | 9.26 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0524 | 1.200 | 8.25 | 9.90 | [0 - 0.3] |
returnOnEquityTTM | 0.0648 | 1.500 | -0.391 | -0.587 | [0.1 - 1] |
payoutRatioTTM | 0.598 | -1.000 | 4.02 | -4.02 | [0 - 1] |
currentRatioTTM | 2.46 | 0.800 | 2.68 | 2.14 | [1 - 3] |
quickRatioTTM | 1.574 | 0.800 | 5.45 | 4.36 | [0.8 - 2.5] |
cashRatioTTM | 0.444 | 1.500 | 8.64 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0169 | -1.500 | 9.72 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 15.84 | 1.000 | 5.24 | 5.24 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.22 | 2.00 | 9.26 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.01 | 2.00 | 8.99 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0207 | -1.500 | 9.92 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0552 | 1.000 | -2.41 | -2.41 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0351 | 1.000 | -1.297 | -1.297 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 3.73 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 1.422 | 0.800 | 3.86 | 3.08 | [0.5 - 2] |
Total Score | 9.35 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 11.60 | 1.000 | 8.93 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0648 | 2.50 | -0.251 | -0.587 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.01 | 2.00 | 9.33 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 5.61 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.22 | 2.00 | 9.26 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.598 | 1.500 | 4.02 | -4.02 | [0 - 1] |
pegRatioTTM | 0.0521 | 1.500 | -2.99 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0443 | 1.000 | -1.393 | 0 | [0.1 - 0.5] |
Total Score | 3.85 |
HAEMATO AG
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators